AxiosCenter·
AI brings savings to clinical trials: study
Artificial intelligence isn't just speeding up early-stage drug development, it's starting to unlock millions of dollars' worth of new efficiencies in clinical trials on cancer treatments, research shared first with Axios shows. Why it matters: AI-powered tools could shave months off time-consuming processes like recruiting and enrolling patients, monitoring results and interpreting data. That could free up resources for more clinical studies and possibly lower the high failure rate for new dru…
Read at Axios →
